Cathie Wood Goes Shopping For Stock of Jack Dorsey's Block — Ark Invest Bolsters Portfolio With Archer Av

On Monday, Cathie Wood-led Ark Invest made a series of trades, with a significant purchase of shares in Block Inc (NYSE:SQ) standing out.

The Block Trade

Ark Invest's acquisition of 18,574 shares of Block underscores Wood's confidence in the company led by Jack Dorsey. The trade, valued at $811,869, was made through ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW). Block shares closed at $43.71 on Monday.

Despite facing challenges, including a controversial report by Hindenburg Research, Wood remains bullish on Block's prospects. The purchase is seen as a reaffirmation of Ark's stance, emphasizing the fund's long-term investment strategy and belief in Block's innovative approach to financial services.

Archer Aviation and CRISPR Therapeutics

Alongside the Block acquisition, Ark Invest also bolstered its position in Archer Aviation (NYSE:ACHR) and CRISPR Therapeutics AG (NASDAQ:CRSP). The fund management company purchased 163,809 Archer shares through ARKK and ARK Autonomous Technology & Robotics ETF (BATS:ARKQ). and 113,772 CRISPR shares on Monday through ARKK, and ARK Genomic Revolution ETF (BATS:ARKG). The transactions were estimated to be worth $846,892 and $4.8 million respectively. Archer shares closed at $5.17 on Monday, while CRISPR shares ended that day’s session at $42.51.

The fund's bullish stance on flying cars is evident with the purchase of 139,858 shares of Archer Aviation, a company at the forefront of the urban air mobility revolution.

The investment in 81,413 shares of CRISPR Therapeutics, a leader in the genome editing space, aligns with Ark's focus on innovative companies. CRISPR's groundbreaking technologies hold the promise of revolutionizing medicine, making it a significant addition to Ark's portfolio.

Other Key Trades:

Ark Invest purchased 37,340 shares of Pacific Biosciences of California (NASDAQ:PACB), a renowned name in the field of genomics through ARKK and ARKG.
The fund also acquired 104,164 shares of Ginkgo Bioworks Holdings Inc (NYSE:DNA), a company known for its cell programming capabilities through ARKK and ARKG.
47,653 shares of Markforged Holding Corp (NYSE:MKFG) were added to Ark's holdings through ARKQ and ARK Space Exploration & Innovation ETF (BATS:ARKX).

Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal

The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.

ACHRArcher Aviation Inc

$5.87-0.76%

Overview

ARKGARK Genomic Revolution ETF

$28.330.75%

ARKKARK Innovation ETF

$74.010.23%

ARKQARK Autonomous Technology & Robotics ETF

$130.330.55%

ARKWARK Next Generation Internet ETF

$142.340.69%

ARKXARK Space & Defense Innovation ETF